Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features

Cover Page

Cite item

Full Text

Abstract

Acute lymphoblastic leukemia (ALL) manifested by eosinophilia (>1.5 × 109/L) in peripheral blood is extremely rare, less than 1 % of all ALL cases. A characteristic feature of patients with ALL and eosinophilia is the absence of blasts in the peripheral blood, which can make early diagnosis of ALL difficult. The article describes the clinical case of 2-year-old patient with ALL and eosinophilia. due to the wide variety of etiologic factors of eosinophilia, which include allergic, infectious, immune agents, and a high risk of developing severe lesions of internal organs, physicians should conduct a broad differential diagnosis with the mandatory inclusion of malignant neoplasms in the diagnostic series. precise determination of the etiology of eosinophilia allows the correct diagnosis and etiotropic treatment.

About the authors

O. D. Gurieva

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Author for correspondence.
Email: swimmer96ok@gmail.com
ORCID iD: 0000-0002-0050-0721

Oksana Dmitrievna Gurieva

24 Kashirskoe Shosse, Moscow 115478 

Russian Federation

T. T. Valiev

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

ORCID iD: 0000-0002-1469-2365

24 Kashirskoe Shosse, Moscow 115478 

Russian Federation

I. N. Serebryakova

N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

24 Kashirskoe Shosse, Moscow 115478 

Russian Federation

References

  1. Shomali W., Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol 2022;97(1):129—48. doi: 10.1002/ajh.26352
  2. Agudo M., Santos F., Teixeira Reis A. et al. Idiopathic hypereosinophilic syndrome: a case report. Cureus 2023;15(6):e39964. doi: 10.7759/cureus.39964
  3. Abo Shdid R., Azrieh B., Alebbi S. et al. Idiopathic hypereosinophilic syndrome with multiple organ involvement. Case Rep Oncol 2021;14(1):249—55. doi: 10.1159/000511396
  4. Arber D.A., Orazi A., Hasserjian R. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127(20):2391 —405. doi: 10.1182/blood-2016-03-643544
  5. Santos A., Loureiro C., Chieira C. [Idiopathic hypereosinophilic syndrome: case report]. Rev Port Imunoalergologia 2008;16(1):93—105. (In Portuguese).
  6. Pallesen KA.U., Herlin T., Holm M. et al. Idiopathic hypereosinophilic syndrome: a rare diagnosis in children. Clin Case Rep 2020;8(10): 2013-6. doi: 10.1002/ccr3.3165
  7. Valent P., Klion D., Horny H.P. et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012;130(3):607—12.e9. doi: 10.1016/j.jaci.2012.02.019
  8. Nemchenko I.S. Myeloproliferative diseases with eosinophilia: clinical features, diagnostics, treatment. Dis. . candidate of medical sciences. Moscow, 2016. 111 p. Available at: https://blood.ru/documents/scientific%20council/nemchenko.pdf. (In Russ.).
  9. Radford D.J., Garlick R.B., Pohlner P.G. Multiple valvar replacements for hypereosinophilic syndrome. Cardiol Young 2002;12(1):67—70. doi: 10.1017/s1047951102000136
  10. Ferruzzi V., Santi E., Gurdo G. et al. Acute lymphoblastic leukemia with hypereosinophilia in a child: case report and literature review. Int J Environ Res Public Health 2018;15(6):1169. doi: 10.3390/ijerph15061169
  11. Geltner D., Friedman G., Naparstek E. et al. Acute lymphoblastic leukemia. Its occurrence with “Hypereosinophilic syndrome” and bilateral spontaneous pneumothorax. Arch Intern Med 1978;138(2):292—3. doi: 10.1001/archinte.1978.03630260082021
  12. Lopina E.A., Dushina A.G., Libis R.A. Idiopathic hypereosinophilic syndrome. A clinical case. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2022;12(5):394—400. (In Russ.). doi: 10.20514/2226-6704-2022-12-5-394-400
  13. Narayanan G., Soman L.V., Kumar R. Hypereosinophilia: a rare presentation of acute lymphoblastic leukaemia. J Postgrad Med 2018;64(1):50—2. doi: 10.4103/jpgm.JPGM_681_16
  14. Ayhan A.C., Timur C., Ayhan Y. et al. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report. Acta Haematol 2012;127(2):90—2. doi: 10.1159/000333085
  15. Sahu K.K., Malhotra P., Khadwal A. et al. Hypereosinophilia in acute lymphoblastic leukemia: two cases with review of literature. Indian J Hematol Blood Transfus 2015;31(4):460— 5. doi: 10.1007/s12288-014-0436-7
  16. Rezamand A., Ghorashi Z., Ghorashi S., Nezami N. Eosinophilic presentation of acute lymphoblastic leukemia. Am J Case Rep 2013;14:143-6. doi: 10.12659/AJCR.883905
  17. Akezheva K.A., Aleshina O.A., Vasileva A.N. et al. Acute promyelocytic leukemia presenting with basophilia: diagnostic features and clinical observation. MD-Onco 2024;4(2):65-70. (In Russ.). doi: 10.17650/2782-3202-2024-4-2-65-70
  18. Thomsen G.N., Christoffersen M.N., Lindegaard H.M. et al. The multidisciplinary approach to eosinophilia. Front Oncol 2023;13:1193730. doi: 10.3389/fonc.2023.1193730
  19. Turkina A.G., Nemchenko I.S., Tsyba N.N. et al. Clinical guidelines for the diagnosis and treatment of myeloproliferative diseases with eosinophilia. Available at: https://npngo.ru/uploads/media_document/288/b44482ac-441a-4de2-8777-2a689a6bdaa5.pdf (accessed 01.05.2024). (In Russ.).
  20. Schwaab J., Jawhar M., Naumann N. et al. Diagnostic challenges in the work up of hypereosinophilia: pitfalls in bone marrow core biopsy interpretation. Ann Hematol 2016;95(4):557—62. doi: 10.1007/s00277-016-2598-x
  21. Pozdnyakova O., Orazi A., Kelemen K. et al. Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2. Am J Clin Pathol 2021;155(2):160—78. doi: 10.1093/ajcp/aqaa208

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.